2425 55th Street, Suite 210 Boulder, CO 80301 303-420-4420

Empowering proteins to better treat diseases

Our diversified product pipeline includes treatments for hematological and endocrine disorders, cancer and infectious diseases. We intend to commercialize these products independently and through strategic alliances with corporate partners.

Technology

We use two protein engineering technologies, Site-Specific PEGylation and ImmunoFusion Protein technology to create our proprietary products. Both technologies increase a protein's effective size and slow its clearance from the body.

 

Pipeline

Bolder BioTechnology has a diversified pipeline of proprietary, long-acting human protein pharmaceuticals that include potential treatments for hematological and endocrine disorders, cancer and infectious disease.

BioDefense

The U.S. government is actively supporting identification and development of drugs to prevent or treat the complications of acute, high dose radiation exposure,such as might occur following a nuclear power plant accident or detonation of a nuclear weapon.